Literature DB >> 6086014

Enzyme immunohistochemistry: technical aspects.

K Sheibani1, R R Tubbs.   

Abstract

The enzyme immunohistochemical techniques developed during the past decade have contributed greatly to our understanding of disease processes and have become an essential tool in the evaluation of many disease states. The availability of these techniques permits the visual localization of tissue antigens in permanent preparation with the potential for visualization of adjacent tissue morphology. This paper outlines the theoretical principles underlying immunohistochemical techniques, the new technical developments and pitfalls of currently available techniques, characterization of nonhazardous chromogens, and quality control for these procedures.

Mesh:

Substances:

Year:  1984        PMID: 6086014

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  27 in total

1.  Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study.

Authors:  L M Weiss; Y Y Chen; X F Liu; D Shibata
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  Rearrangement of kappa-chain and T-cell receptor beta-chain genes in malignant lymphomas of "T-cell" phenotype.

Authors:  K Sheibani; A Wu; J Ben-Ezra; R Stroup; H Rappaport; C Winberg
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  A focused approach to patients with cancer of unknown primary site.

Authors:  F J Meyers; J P Lewis
Journal:  West J Med       Date:  1986-09

4.  Diagnostic immunopathology.

Authors:  P A Cancilla; A J Cochran; F Naeim; J W Said
Journal:  West J Med       Date:  1986-07

5.  Sensitive avidin biotin based technique for identifying liver membrane antigens in tissue sections.

Authors:  J Sipos; B M McFarlane; R Williams; I G McFarlane
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

6.  Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastases.

Authors:  B P Barna; M J Thomassen; M Maier; S V Medendorp; R R Tubbs; T Chiang; P Zhou; B Yen-Lieberman; S Singh-Burgess; S D Deodhar
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

7.  Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.

Authors:  K Sonouchi; T A Hamilton; C S Tannenbaum; R R Tubbs; R Bukowski; J H Finke
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

Authors:  P S Randhawa; R Jaffe; A J Demetris; M Nalesnik; T E Starzl; Y Y Chen; L M Weiss
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

9.  Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.

Authors:  J I Diaz; M G Edinger; M H Stoler; R R Tubbs
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

10.  Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma.

Authors:  D Shibata; M Tokunaga; Y Uemura; E Sato; S Tanaka; L M Weiss
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.